The recent challenges in global chains have highlighted the necessity of securing critical medications like Ivermectin. Trusting on overseas manufacturers exposes nations to significant vulnerabilities, including shipping delays, cost fluctuations, and even trade risks. Shifting towards domestic procurement of Ivermectin offers a multitude of upsid